{
  "input": {
    "mode": "build_chain",
    "query": {
      "entity": "Generalised pustular psoriasis",
      "relation": "indication"
    },
    "hypotheses": [
      {
        "id": "H1",
        "candidate": {
          "id": "drug_acitretin",
          "name": "Acitretin"
        },
        "mechanism_outline": "",
        "priority": 1.0
      },
      {
        "id": "H2",
        "candidate": {
          "id": "drug_apremilast",
          "name": "Apremilast"
        },
        "mechanism_outline": "",
        "priority": 0.95
      },
      {
        "id": "H3",
        "candidate": {
          "id": "drug_etanercept",
          "name": "Etanercept"
        },
        "mechanism_outline": "",
        "priority": 0.9
      },
      {
        "id": "H4",
        "candidate": {
          "id": "drug_infliximab",
          "name": "Infliximab"
        },
        "mechanism_outline": "",
        "priority": 0.85
      },
      {
        "id": "H5",
        "candidate": {
          "id": "drug_secukinumab",
          "name": "Secukinumab"
        },
        "mechanism_outline": "",
        "priority": 0.8
      },
      {
        "id": "H6",
        "candidate": {
          "id": "drug_cyclosporine",
          "name": "Cyclosporine"
        },
        "mechanism_outline": "",
        "priority": 0.75
      },
      {
        "id": "H7",
        "candidate": {
          "id": "drug_methotrexate",
          "name": "Methotrexate"
        },
        "mechanism_outline": "",
        "priority": 0.7
      },
      {
        "id": "H8",
        "candidate": {
          "id": "drug_adalimumab",
          "name": "Adalimumab"
        },
        "mechanism_outline": "",
        "priority": 0.6499999999999999
      },
      {
        "id": "H9",
        "candidate": {
          "id": "drug_interleukin_17_inhibitors",
          "name": "Interleukin-17 inhibitors"
        },
        "mechanism_outline": "",
        "priority": 0.6
      },
      {
        "id": "H10",
        "candidate": {
          "id": "drug_topical_corticosteroids",
          "name": "Topical corticosteroids"
        },
        "mechanism_outline": "",
        "priority": 0.55
      },
      {
        "id": "H11",
        "candidate": {
          "id": "drug_ustekinumab",
          "name": "Ustekinumab"
        },
        "mechanism_outline": "",
        "priority": 0.5
      },
      {
        "id": "H12",
        "candidate": {
          "id": "drug_thalidomide",
          "name": "Thalidomide"
        },
        "mechanism_outline": "",
        "priority": 0.44999999999999996
      }
    ],
    "tegraph_snapshot": {
      "nodes": [],
      "edges": [],
      "round_index": 1
    },
    "constraints": {
      "require_disjoint_paths": 2,
      "max_new_nodes": 50,
      "max_new_edges": 64,
      "batched": true
    },
    "ablation_config": {
      "enable_debate": true,
      "enable_skeptic": true,
      "enable_pi_interrupts": true,
      "enable_textual_feedback": true,
      "enable_heuristic_transfer": true,
      "enable_seed_regen": true,
      "weights": {
        "path_disjointness": 1.0
      },
      "mode": "graph"
    }
  },
  "output": {
    "graph_updates": {
      "add_nodes": [
        {
          "id": "drug_acitretin",
          "type": "Drug",
          "label": "Acitretin",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "drug_apremilast",
          "type": "Drug",
          "label": "Apremilast",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "drug_etanercept",
          "type": "Drug",
          "label": "Etanercept",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "drug_infliximab",
          "type": "Drug",
          "label": "Infliximab",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "drug_secukinumab",
          "type": "Drug",
          "label": "Secukinumab",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "drug_cyclosporine",
          "type": "Drug",
          "label": "Cyclosporine",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "drug_methotrexate",
          "type": "Drug",
          "label": "Methotrexate",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "drug_adalimumab",
          "type": "Drug",
          "label": "Adalimumab",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "drug_interleukin_17_inhibitors",
          "type": "Drug",
          "label": "Interleukin-17 inhibitors",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "drug_topical_corticosteroids",
          "type": "Drug",
          "label": "Topical corticosteroids",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "drug_ustekinumab",
          "type": "Drug",
          "label": "Ustekinumab",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "drug_thalidomide",
          "type": "Drug",
          "label": "Thalidomide",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "d_generalised_pustular_psoriasis",
          "type": "Disease",
          "label": "Generalised Pustular Psoriasis",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "t_inflam_regulation",
          "type": "Target",
          "label": "Inflammatory Regulation",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "p_psoriasis_pathway",
          "type": "Pathway",
          "label": "Psoriasis Pathway",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "p_acitretin_pathway",
          "type": "Pathway",
          "label": "Acitretin Pathway",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "p_apremilast_pathway",
          "type": "Pathway",
          "label": "Apremilast Pathway",
          "attrs": {
            "agent": "Proponent"
          }
        }
      ],
      "add_edges": [
        {
          "source": "drug_acitretin",
          "target": "t_inflam_regulation",
          "relation": "acts_on",
          "weight": 0.85,
          "agent": "Proponent",
          "rationale": "Acitretin已知对炎症调节的影响"
        },
        {
          "source": "drug_acitretin",
          "target": "p_acitretin_pathway",
          "relation": "involved_in",
          "weight": 0.75,
          "agent": "Proponent",
          "rationale": "Acitretin作用于特定通路"
        },
        {
          "source": "p_acitretin_pathway",
          "target": "d_generalised_pustular_psoriasis",
          "relation": "causes",
          "weight": 0.7,
          "agent": "Proponent",
          "rationale": "通路调节与红斑性脓疱性银屑病的关联"
        },
        {
          "source": "drug_apremilast",
          "target": "t_inflam_regulation",
          "relation": "acts_on",
          "weight": 0.85,
          "agent": "Proponent",
          "rationale": "Apremilast已知对炎症调节的影响"
        },
        {
          "source": "drug_apremilast",
          "target": "p_apremilast_pathway",
          "relation": "involved_in",
          "weight": 0.75,
          "agent": "Proponent",
          "rationale": "Apremilast作用于特定通路"
        },
        {
          "source": "p_apremilast_pathway",
          "target": "d_generalised_pustular_psoriasis",
          "relation": "causes",
          "weight": 0.7,
          "agent": "Proponent",
          "rationale": "通路调节与红斑性脓疱性银屑病的关联"
        },
        {
          "source": "drug_etanercept",
          "target": "t_inflam_regulation",
          "relation": "acts_on",
          "weight": 0.85,
          "agent": "Proponent",
          "rationale": "Etanercept已知对炎症调节的影响"
        },
        {
          "source": "drug_etanercept",
          "target": "p_psoriasis_pathway",
          "relation": "involved_in",
          "weight": 0.75,
          "agent": "Proponent",
          "rationale": "Etanercept作用于相关通路"
        },
        {
          "source": "p_psoriasis_pathway",
          "target": "d_generalised_pustular_psoriasis",
          "relation": "causes",
          "weight": 0.7,
          "agent": "Proponent",
          "rationale": "通路调节与红斑性脓疱性银屑病的关联"
        }
      ]
    },
    "subconclusions": [
      {
        "id": "C1",
        "text": "Acitretin 和 Apremilast 通过调节炎症靶点影响红斑性脓疱性银屑病",
        "confidence": "high"
      },
      {
        "id": "C2",
        "text": "Etanercept通过影响相关通路参与红斑性脓疱性银屑病的治疗",
        "confidence": "high"
      }
    ],
    "assumptions": [
      "所有药物具备达到靶器官的生物利用度"
    ],
    "uncertainties": [
      "未验证的新治疗作用可能存在个体差异"
    ],
    "next_focus_for_pi": [
      "是否需要进一步探索其他药物候选或机制路径"
    ]
  }
}